Background The role of temporary ovarian suppression with gonadotropin-releasing
hormone analogues (GnRHa) in the prevention of chemotherapy-induced premature …

Survivorship issues are an area of crucial importance to be addressed as early as possible
by all health care providers dealing with cancer patients. In women diagnosed during their …

This selection from the NCCN Guidelines for Adolescent and Young Adult (AYA) Oncology
focuses on treatment and management considerations for AYA patients with cancer …

In the last years, thanks to the improvement in the prognosis of cancer patients, a growing
attention has been given to the fertility issues. International guidelines on fertility …

Context Premenopausal patients with breast cancer are at high risk of premature ovarian
failure induced by systemic treatments, but no standard strategies for preventing this …

The overall increase in cancer prevalence and the significant increase in long-term survival
have generated worldwide interest in preserving fertility in young women exposed to …

Importance Chemotherapy may result in a detrimental effect on ovarian function and fertility
in premenopausal women undergoing treatment for early-stage breast cancer (EBC). To …

OBJECTIVE: To estimate whether gonadotropin-releasing hormone (GnRH) analog
administration during chemotherapy can protect against development of ovarian toxicity …

OBJECTIVE: To estimate the effectiveness of gonadotropin-releasing hormone (GnRH)
analogues cotreatment in preventing chemotherapy-induced amenorrhea in young breast …

BACKGROUND Current options for female fertility preservation in the face of cytotoxic
treatments include embryo, oocyte and ovarian tissue cryopreservation. However these …